Search Results

An Interview With John H. Rundback, MD

Reflections on TACIT, what's next for CREST, and a close look at the field of interventional radiology.

Asymptomatic CAS Trial Designs

John H. Rundback, MD, of the TACIT trial, and Sumaira Macdonald, MD, of ACST-2 discuss the necessary elements to evaluate the current state of care for treating asymptomatic carotid stenosis.

By John H. Rundback, MD and Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD

Entry and Exit Strategies

By John H. Rundback, MD, FAHA, FSVM, FSIR

Guest Chief Medical Editor's Page

The Art of Vessel Access

By John H. Rundback, MD, FSVM, FAHA, FSIR

TRA for Hemodialysis Access Interventions

Transradial access options in dysfunctional hemodialysis fistula management.

By John H. Rundback, MD, FSVM, FAHA, FSIR, and Kevin “Chaim” Herman, MD

Editor's Challenge

A panel of interventional experts weighs in on how they would access and treat a series of challenging access case presentations.
With John H. Rundback, MD, FSVM, FAHA, FSIR; Mark W. Burket, MD; Bruce H. Gray, DO; Craig Walker, MD; and Michael Wholey, MD, MBA

An Extensive, Calcified CTO in the Superficial Femoral Artery

Moderator: John H. Rundback, MD, FAHA, FSVM, FSIR
Panel: Michael Miller Jr, MD, FSIR; Miguel Montero-Baker, MD; and Vincent Varghese, DO, FACC, FSCAI

Editor's Access and Closure Challenge: How Would You Do It?

Endovascular Today's Guest Chief Medical Editor, Dr. John H. Rundback, presented four challenging PAD cases to a panel of interventional experts and asked them to answer a series of questions on their preferred methods for assessment, access, and treatment.

With John H. Rundback, MD, FSVM, FAHA, FSIR; Mark Fleming, MD, FACS, RPVI; Paramjit Chopra, MD; and J. Michael Bacharach, MD, FACC, FSCAI, MPH

Update on the TACIT Trial

New endpoints and new data have made TACIT even more critical.

By Endovascular Today interviews John H. Rundback, MD

Provisional Stenting of the Iliac Arteries

This technique may provide a more cost-effective and patient-specific option.

By John H. Rundback, MD

CTOs: What Not to Do

Technological considerations for the infrainguinal arterial bed from one cardiology-based team.

By Adam Zybulewski, BA; John H. Rundback, MD; and Stuart Miller, MD

Interventional Strategies for Atherosclerotic Popliteal Disease

A review of the limitations and therapeutic options available for treating this challenging segment.

By John H. Rundback, MD, and Luis Rodriguez, Jr, MD

Embolic Protection in Femoropopliteal Artery Intervention

What devices are available and when is it necessary?

By Hank J. Freeman, MD, and John H. Rundback, MD

Embolization During Popliteal and Tibial Intervention for CLTI

A look at the incidence and impact on outcomes.

By John H. Rundback, MD; Peter A. Schneider, MD; and Richard E. Fulton, MD

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

Subintimal Tibial Angioplasty for Critical Limb Ischemia

One institution's experience treating tibial chronic total occlusions with subintimal balloon angioplasty.

By John H. Rundback, MD, FAHA, FSVM, FSIR; Chaim Herman, MD; and Marcelo Mendez, BA

One Question… How Will You Apply Drug-eluting Stents in Your SFA Practice?

Featuring Gary M. Ansel, MD; Bruce H. Gray, DO, MSVM, FSCAI; John H. Rundback, MD; and Evan Lipsitz, MD